Skip to main content
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1985 Jul;61(1):39–43.

Absence of autoimmune serological reactions in chronic non A, non B viral hepatitis.

I R Mackay, I H Frazer, B H Toh, J S Pedersen, H J Alter
PMCID: PMC1577251  PMID: 3930108

Abstract

In 18 cases of chronic liver disease due to non-A, non-B hepatitis virus(es) in which the diagnosis was established by transmission, including chimpanzee inoculation in nine, sera were tested for the autoantibodies characteristically associated with autoimmune chronic active hepatitis. The frequency of autoantibodies to nuclear, smooth muscle, cytofilament, mitochondrial and liver membrane antigens was low, being not greater than that recorded for a normal population, and the few positive reactions obtained were at very low titre. These findings suggest that among cases of 'HBsAg negative' chronic hepatitis, those due to NANB infection are distinguishable from those due to autoimmune chronic hepatitis by negative serological tests for autoantibodies.

Full text

PDF
42

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bretherton L., Brown C., Pedersen J. S., Toh B. H., Clarke F. M., Mackay I. R., Gust I. D. ELISA assay for IgG autoantibody to G-actin: comparison of chronic active hepatitis and acute viral hepatitis. Clin Exp Immunol. 1983 Mar;51(3):611–616. [PMC free article] [PubMed] [Google Scholar]
  2. Dienstag J. L. Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features. Gastroenterology. 1983 Aug;85(2):439–462. [PubMed] [Google Scholar]
  3. Farrow L. J., Stewart J. S., Stern H., Clifford R. E., Smith H. G., Zuckerman A. J. Non-A, non-B hepatitis in West London. Lancet. 1981 May 2;1(8227):982–984. doi: 10.1016/s0140-6736(81)91741-4. [DOI] [PubMed] [Google Scholar]
  4. Frazer I. H., Kronborg I. J., Mackay I. R. Antibodies to liver membrane antigens in chronic active hepatitis (CAH). II. Specificity for autoimmune CAH. Clin Exp Immunol. 1983 Oct;54(1):213–218. [PMC free article] [PubMed] [Google Scholar]
  5. Frøoland S. S., Teien A. N., Ulstrup J. C. Acute non-A, non-B hepatitis in Norway. Clinical, epidemiological, and immunological characteristics in comparsion with hepatitis A. Scand J Gastroenterol. 1982 Aug;17(5):593–599. doi: 10.3109/00365528209181064. [DOI] [PubMed] [Google Scholar]
  6. Fujinami R. S., Oldstone M. B., Wroblewska Z., Frankel M. E., Koprowski H. Molecular mimicry in virus infection: crossreaction of measles virus phosphoprotein or of herpes simplex virus protein with human intermediate filaments. Proc Natl Acad Sci U S A. 1983 Apr;80(8):2346–2350. doi: 10.1073/pnas.80.8.2346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hodges J. R., Millward-Sadler G. H., Wright R. Chronic active hepatitis: the spectrum of disease. Lancet. 1982 Mar 6;1(8271):550–552. doi: 10.1016/s0140-6736(82)92056-6. [DOI] [PubMed] [Google Scholar]
  8. Hooper B., Whittingham S., Mathews J. D., Mackay I. R., Curnow D. H. Autoimmunity in a rural community. Clin Exp Immunol. 1972 Sep;12(1):79–87. [PMC free article] [PubMed] [Google Scholar]
  9. Knodell R. G., Conrad M. E., Ishak K. G. Development of chronic liver disease after acute non-A, non-B post-transfusion hepatitis. Role of gamma-globulin prophylaxis in its prevention. Gastroenterology. 1977 May;72(5 Pt 1):902–909. [PubMed] [Google Scholar]
  10. Pedersen J. S., Toh B. H., Locarnini S. A., Gust I. D., Shyamala G. N. Autoantibody to intermediate filaments in viral hepatitis. Clin Immunol Immunopathol. 1981 Nov;21(2):154–161. doi: 10.1016/0090-1229(81)90204-x. [DOI] [PubMed] [Google Scholar]
  11. Pedersen J. S., Toh B. H., Mackay I. R., Tait B. D., Gust I. D., Kastelan A., Hadzic N. Segregation of autoantibody to cytoskeletal filaments, actin and intermediate filaments with two types of chronic active hepatitis. Clin Exp Immunol. 1982 Jun;48(3):527–532. [PMC free article] [PubMed] [Google Scholar]
  12. Robinson W. S. The enigma of non-a, non-b hepatitis. J Infect Dis. 1982 Mar;145(3):387–387. doi: 10.1093/infdis/145.3.387. [DOI] [PubMed] [Google Scholar]
  13. Shimizu Y. K., Feinstone S. M., Purcell R. H., Alter H. J., London W. T. Non-A, non-B hepatitis: ultrastructural evidence for two agents in experimentally infected chimpanzees. Science. 1979 Jul 13;205(4402):197–200. doi: 10.1126/science.451589. [DOI] [PubMed] [Google Scholar]
  14. Tage-Jensen U., Permin H., Hardt F., Juhl E., Mathiesen L. R., Nielsen J. O., Ranek L. Circulating autoantibodies in patients with acute viral hepatitis. Relation to etiology and clinical course. Scand J Gastroenterol. 1980;15(2):229–235. doi: 10.3109/00365528009181460. [DOI] [PubMed] [Google Scholar]
  15. Toh B. H. Smooth muscle autoantibodies and autoantigens. Clin Exp Immunol. 1979 Dec;38(3):621–628. [PMC free article] [PubMed] [Google Scholar]
  16. Whittingham S., Mathews J. D., Schanfield M. S., Tait B. D., Mackay I. R. Interaction of HLA and Gm in autoimmune chronic active hepatitis. Clin Exp Immunol. 1981 Jan;43(1):80–86. [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES